Product Code: SR112025A15519
Japan genomics market size reached USD 2,271 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,333 Million by 2033, exhibiting a growth rate (CAGR) of 13.9% during 2025-2033. The increasing incidences of genetic diseases and conditions, which has enhanced the demand for genetic testing and sequencing services, are primarily driving the market.
Genomics refers to a branch of biology that focuses on studying the complete set of an organism's genes, known as its genome. It encompasses the analysis of an organism's DNA, including its sequence, structure, function, and variations. Genomics plays an essential role in understanding the genetic makeup of living organisms, from humans to plants and microbes. This field has far-reaching implications for various aspects of life sciences and healthcare. It enables researchers to unravel the genetic basis of diseases, identify potential drug targets, and develop personalized medicine approaches. Genomics also aids in the study of evolution by comparing genomes across species to trace common ancestry and evolutionary adaptations. Advancements in technology, such as high-throughput DNA sequencing, have revolutionized genomics, making it more accessible and affordable. As a result, genomics has led to breakthroughs in fields like genetics, medicine, agriculture, and conservation, offering insights into the fundamental building blocks of life and the potential to address complex biological questions and challenges.
Japan Genomics Market Trends:
The genomics market in Japan is being propelled forward by a multitude of compelling drivers. Firstly, the rapid advancements in sequencing technology have enabled the cost-effective analysis of an individual's entire genetic code, driving genomics into mainstream healthcare. Furthermore, the increasing prevalence of genetic diseases and the demand for personalized medicine have fostered a growing awareness of the potential benefits of genomics, thus boosting market growth. In addition to this, government initiatives and research funding in Japan have played a pivotal role in expanding the genomics market. Collaborative efforts between public and private sectors have resulted in extensive genome mapping projects and the sharing of genomic data, facilitating research and innovation. Concurrently, the rising adoption of genomics in agriculture, with applications like precision breeding and crop improvement, has opened up a substantial market opportunity. Moreover, the ever-evolving landscape of AI and data analytics has expedited the interpretation of complex genomic data, making it more accessible and actionable. These technologies have revolutionized drug discovery and development, further energizing the genomics market in Japan.
Japan Genomics Market Segmentation:
Component Insights:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Technology Insights:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Application Insights:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
End User Insights:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan genomics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan genomics market?
- What is the breakup of the Japan genomics market on the basis of component?
- What is the breakup of the Japan genomics market on the basis of technology?
- What is the breakup of the Japan genomics market on the basis of application?
- What is the breakup of the Japan genomics market on the basis of end user?
- What are the various stages in the value chain of the Japan genomics market?
- What are the key driving factors and challenges in the Japan genomics?
- What is the structure of the Japan genomics market and who are the key players?
- What is the degree of competition in the Japan genomics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Genomics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Genomics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Genomics Market - Breakup by Component
- 6.1 Products
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
- 6.1.3.1 Instruments and Software
- 6.1.3.2 Consumables and Reagents
- 6.1.4 Market Forecast (2025-2033)
- 6.2 Services
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
- 6.2.3.1 Core Genomics Services
- 6.2.3.2 NGS-Based Services
- 6.2.3.3 Biomarker Translation Services
- 6.2.3.4 Computational Services
- 6.2.3.5 Others
- 6.2.4 Market Forecast (2025-2033)
7 Japan Genomics Market - Breakup by Technology
- 7.1 Sequencing
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Microarray
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Polymerase Chain Reaction
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Nucleic Acid Extraction and Purification
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)
8 Japan Genomics Market - Breakup by Application
- 8.1 Functional Genomics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Epigenomics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Biomarkers Discovery
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Pathway Analysis
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)
9 Japan Genomics Market - Breakup by End User
- 9.1 Research Centers
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Others
- 9.4.1 Historical and Current Market Trends (2019-2024)
- 9.4.2 Market Forecast (2025-2033)
10 Japan Genomics Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Genomics Market - Industry Analysis
- 12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
13 Appendix